These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10566143)
1. The diversity of T-cell co-stimulation in the induction of antitumor immunity. Schlom J; Hodge JW Immunol Rev; 1999 Aug; 170():73-84. PubMed ID: 10566143 [TBL] [Abstract][Full Text] [Related]
2. Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity. Hodge JW; McLaughlin JP; Abrams SI; Shupert WL; Schlom J; Kantor JA Cancer Res; 1995 Aug; 55(16):3598-603. PubMed ID: 7543017 [TBL] [Abstract][Full Text] [Related]
3. Vaccine therapy of established tumors in the absence of autoimmunity. Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7. Akagi J; Hodge JW; McLaughlin JP; Gritz L; Mazzara G; Kufe D; Schlom J; Kantor JA J Immunother; 1997 Jan; 20(1):38-47. PubMed ID: 9101412 [TBL] [Abstract][Full Text] [Related]
5. A triad of costimulatory molecules synergize to amplify T-cell activation in both vector-based and vector-infected dendritic cell vaccines. Schlom J; Sabzevari H; Grosenbach DW; Hodge JW Artif Cells Blood Substit Immobil Biotechnol; 2003 May; 31(2):193-228. PubMed ID: 12751840 [TBL] [Abstract][Full Text] [Related]
6. A triad of costimulatory molecules synergize to amplify T-cell activation. Hodge JW; Sabzevari H; Yafal AG; Gritz L; Lorenz MG; Schlom J Cancer Res; 1999 Nov; 59(22):5800-7. PubMed ID: 10582702 [TBL] [Abstract][Full Text] [Related]
7. Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules (B7-1, ICAM-1, LFA-3). Shankar P; Schlom J; Hodge JW Vaccine; 2001 Dec; 20(5-6):744-55. PubMed ID: 11738738 [TBL] [Abstract][Full Text] [Related]
8. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity. Aarts WM; Schlom J; Hodge JW Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537 [TBL] [Abstract][Full Text] [Related]
9. Vector-based delivery of tumor-associated antigens and T-cell co-stimulatory molecules in the induction of immune responses and anti-tumor immunity. Hodge JW; Grosenbach DW; Schlom J Cancer Detect Prev; 2002; 26(4):275-91. PubMed ID: 12430632 [TBL] [Abstract][Full Text] [Related]
10. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals. Jaiswal AI; Dubey C; Swain SL; Croft M Int Immunol; 1996 Feb; 8(2):275-85. PubMed ID: 8671613 [TBL] [Abstract][Full Text] [Related]
11. Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development. Charles LG; Xie YC; Restifo NP; Roessler B; Sanda MG World J Urol; 2000 Apr; 18(2):136-42. PubMed ID: 10854149 [TBL] [Abstract][Full Text] [Related]
12. The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation. Kalus RM; Kantor JA; Gritz L; Gómez Yafal A; Mazzara GP; Schlom J; Hodge JW Vaccine; 1999 Feb; 17(7-8):893-903. PubMed ID: 10067696 [TBL] [Abstract][Full Text] [Related]
13. Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules. Hodge JW; Rad AN; Grosenbach DW; Sabzevari H; Yafal AG; Gritz L; Schlom J J Natl Cancer Inst; 2000 Aug; 92(15):1228-39. PubMed ID: 10922408 [TBL] [Abstract][Full Text] [Related]
14. Vaccination with a recombinant vaccinia vaccine containing the B7-1 co-stimulatory molecule causes no significant toxicity and enhances T cell-mediated cytotoxicity. Freund YR; Mirsalis JC; Fairchild DG; Brune J; Hokama LA; Schindler-Horvat J; Tomaszewski JE; Hodge JW; Schlom J; Kantor JA; Tyson CA; Donohue SJ Int J Cancer; 2000 Feb; 85(4):508-17. PubMed ID: 10699923 [TBL] [Abstract][Full Text] [Related]
15. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles. Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030 [TBL] [Abstract][Full Text] [Related]
16. Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects. Grosenbach DW; Barrientos JC; Schlom J; Hodge JW Cancer Res; 2001 Jun; 61(11):4497-505. PubMed ID: 11389081 [TBL] [Abstract][Full Text] [Related]
17. Modified vaccinia virus ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses. Hodge JW; Poole DJ; Aarts WM; Gómez Yafal A; Gritz L; Schlom J Cancer Res; 2003 Nov; 63(22):7942-9. PubMed ID: 14633725 [TBL] [Abstract][Full Text] [Related]
18. Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules. Briones J; Timmerman JM; Panicalli DL; Levy R J Natl Cancer Inst; 2003 Apr; 95(7):548-55. PubMed ID: 12671023 [TBL] [Abstract][Full Text] [Related]
19. Construction and characterization of a recombinant vaccinia virus expressing murine intercellular adhesion molecule-1: induction and potentiation of antitumor responses. Uzendoski K; Kantor JA; Abrams SI; Schlom J; Hodge JW Hum Gene Ther; 1997 May; 8(7):851-60. PubMed ID: 9143911 [TBL] [Abstract][Full Text] [Related]
20. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation. Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]